ADVANTEST CORPORATION FY2027 Q1 Earnings Report

Quick View

Executive Summary

In Q1 FY2026, Advantest reported higher revenue and profits against a backdrop of expanding demand for semiconductor testers used in inference AI, with the most notable development being the expansion of the operating margin to a record-high level. Revenue was ¥3,674.7B (+39.3% year on year), Operating Income was ¥1,899.9B (+53.3%), and Net Income attributable to owners of the parent was ¥1,747.8B (+93.8%). The primary driver of revenue growth was expanding demand for both SoC and memory testers in the Test Systems Business. On the profit side, in addition to improvements in the gross margin and SG&A ratio, a ¥410.8B valuation gain on financial instruments related to strategic investments lifted Profit Before Tax, increasing the Net Income growth rate beyond that of Operating Income.

Factors Affecting Earnings

【Revenue】Revenue was ¥3,674.7B, up +39.3% year on year. The core Test Systems Business generated ¥3,335.6B (+38.7%), accounting for 90.8% of total revenue, driven by expanding demand for SoC and memory testers for inference AI-related applications (ASICs, CPUs, and DRAM). Services, Other Businesses also posted strong growth, with revenue of ¥339.1B (+46.0%), reflecting increased support and service revenue associated with the rise in installed units.

【Profit and Loss】Operating Income was ¥1,899.9B (+53.3%), with the gross margin improving to 69.5% (+4.5pt from 65.1% in the previous year) and the SG&A ratio improving to 18.0% (-1.1pt from 19.2%), resulting in profit growth exceeding revenue growth. Profit Before Tax was ¥2,340.8B (+92.9%), substantially exceeding the growth rate of Operating Income, because a ¥41.1B valuation gain on financial instruments related to strategic investments, included in financial income of ¥44.7B, provided a boost (temporary factor). Net Income was ¥1,747.8B (+93.8%). Excluding the temporary factor, the underlying earnings improvement was close to the Operating Income growth rate (+53.3%); overall, the company can be deemed to have achieved higher revenue and profits.

Segment Analysis

The core Test Systems Business, which accounted for 90.8% of revenue, drove the expansion in earnings. Revenue in this business was ¥3,335.6B (+38.7%), while segment profit before adjustments for share-based compensation expenses was ¥1,907.2B (+50.3%), maintaining a high margin of 57.2%. Services, Other Businesses recorded revenue of ¥339.1B (+46.0%) and profit of ¥85.6B (+216.4%), resulting in a margin of 25.3%. However, the prior-year period’s profit included a ¥25.0B gain on the partial transfer of a business; excluding this item, the underlying profit growth rate was even higher. Corporate eliminations and adjustments expanded to -¥79.4B (from -¥46.2B in the previous year), suggesting an increase in company-wide research and development expenses and other costs. The disparity in segment margins (Test Systems: 57.2% vs. Services, Other Businesses: 25.3%) demonstrates the significant impact that changes in the business mix of the core business have on the consolidated profit margin.

Key Financial Metrics

Profitability: Operating margin of 51.7% (+4.7pt from 47.0% in the previous year), Net margin of 47.6% (+13.4pt from 34.2% in the previous year), and ROE of 16.8%.
Cash flow quality: Operating Cash Flow (OCF)/Net Income of 0.78x (below 1.0x, indicating a slight delay in cash conversion), and FCF of ¥346.1B.
Investment efficiency: Capital expenditures/Depreciation and Amortization of 1.38x (above 1.0x, suggesting a phase of capacity expansion investment).
Financial soundness: Equity Ratio of 68.8% (+0.9pt from 67.9% in the previous year), and current ratio of approximately 266.5%.

Cash Flow Analysis

Operating Cash Flow was ¥1,371.5B (+192.7% year on year), or 0.78x Net Income, below 1.0x. While an increase in inventories (-¥413.5B) and higher corporate income tax payments (-¥1,011.1B) constrained cash conversion, progress in collecting trade receivables (+¥521.3B) provided support. Investing Cash Flow was -¥1,025.5B, mainly due to ¥98.5B in capital expenditures and investments totaling approximately ¥918B in equity and debt financial instruments. Financing Cash Flow was +¥349.7B, with the ¥1,000B issuance of convertible bonds supplementing the funding sources for ¥21.43B in dividends and ¥42.21B in share repurchases. FCF was ¥346.1B, broadly sufficient to cover capital expenditures and dividends. Cash generation is classified as “requiring monitoring,” as OCF fell below Net Income due to inventory accumulation and the increased tax burden.

Quality of Earnings

The difference between Profit Before Tax of ¥2,340.8B and Net Income of ¥1,747.8B was attributable to income tax expense of ¥593.0B (effective tax rate of 25.3%), with no particular divergence observed. Meanwhile, the ¥440.9B difference between Operating Income of ¥1,899.9B and Profit Before Tax was primarily attributable to financial income of ¥44.7B, equivalent to 12.2% of revenue and above the 5% threshold. Of this financial income, ¥41.1B was a valuation gain on financial instruments related to strategic investments, a temporary item with high sensitivity to market conditions. From an accruals perspective, OCF of ¥1,371.5B was below Net Income of ¥1,747.8B, requiring attention regarding the conversion of earnings into cash, particularly due to the increase in inventories.

Earnings Forecast and Guidance

Progress against the full-year forecast was 21.4% for Revenue (¥367.5B/¥1,714.0B), 22.5% for Operating Income (¥189.9B/¥846.0B), and 26.5% for Net Income (¥174.8B/¥660.0B). Compared with the standard progress rate (Q1 = 25%), Revenue and Operating Income were slightly below the benchmark, while Net Income exceeded it; this was largely due to the impact of the temporary valuation gain on financial instruments included in Net Income. The earnings forecast was revised during the quarter. Following an upward revision to the CY26 tester market (TAM) forecast to $13.0-14.5B (approximately +19% versus the previous forecast), the full-year Revenue forecast was raised by ¥294.0B versus the previous forecast, while the Operating Income forecast was raised by ¥218.5B. The upward revision was driven by the accelerating expansion of semiconductor demand for inference AI applications.

Shareholder Returns

Dividend payments during Q1 totaled ¥214.3B (¥143.7B in the year-ago period, +49.2%), and there was no revision to the dividend forecast during the quarter. Share repurchases amounted to ¥422.1B, a substantial increase from ¥154.5B in the year-ago period. Total shareholder returns, combining dividends and share repurchases, amounted to ¥636.4B, resulting in a Total Return Ratio of approximately 9.6% based on the full-year Net Income forecast of ¥6,600B. Total returns during the quarter exceeded FCF of ¥346.1B, with financing from the ¥1,000B issuance of convertible bonds supplementing part of the funding sources.

Catalysts

【Short Term】Attention will focus on the normalization of inventory levels in the next quarter and thereafter, whether there will be a reversal of the financial instrument valuation gain, and progress toward the standard 50% cumulative progress rate at the Q2 earnings announcement. 【Long Term】Key medium- to long-term points of focus include the sustainability of tester demand for inference AI-related semiconductors (ASICs, CPUs, and DRAM), the degree to which the scenario of expansion of the CY26 tester market to $13.0-14.5B is realized, and progress in expanding production capacity for both SoC and memory test systems.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Growth and Capital Efficiency

※Source: Compiled by the Company

Risk Factors

1. Working capital tied up: Inventories increased to ¥2,736.5B (+18.1% year on year), placing pressure on OCF. OCF/Net Income remained at 0.78x, creating risks of impairment losses and inventory adjustments during periods of demand volatility.

2. Dependence on temporary financial income: Of the ¥44.7B in financial income, ¥41.1B was a valuation gain on financial instruments related to strategic investments, representing 12.2% of revenue. This valuation gain is highly sensitive to market conditions, and the growth rate of Profit Before Tax (+92.9%) substantially exceeded that of Operating Income (+53.3%); attention is therefore required regarding any reversal in subsequent periods.

3. Dependence on financing for shareholder returns: Total returns of ¥636.4B, comprising dividends of ¥214.3B and share repurchases of ¥422.1B, exceeded FCF of ¥346.1B. During the quarter, funding was supplemented by the ¥1,000B issuance of convertible bonds. If returns exceeding FCF continue in the future, dependence on external financing may increase.

Key Earnings Highlights

1. The Operating Margin improved by 4.7pt to 51.7% (from 47.0% in the previous year), confirming the strength of operating leverage resulting from improvements in both the gross margin and SG&A ratio. This demonstrates the fixed-cost absorption effect during a period of expanding demand.

2. The Net Income growth rate (+93.8%) substantially exceeded the Operating Income growth rate (+53.3%), with the difference attributable to the ¥41.1B valuation gain on financial instruments related to strategic investments. When evaluating the earnings figures, it is necessary to distinguish between underlying growth based on Operating Income and growth based on Net Income, which includes the valuation gain.

3. OCF/Net Income was 0.78x, below 1.0x, as inventory accumulation and increased tax payments during a period of revenue growth delayed cash conversion. Progress against the full-year plan was favorable at 26.5% for Net Income, but cash flow trends will be a point for monitoring going forward.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥3,731–¥3,976 for a ±1% change in the cost of equity, and ¥3,769–¥3,977 for a ±0.1 change in ω.

Notes:

• The EPS impact of approximately ¥27.3 per share from a ±¥5 change in the assumed exchange rate has been reflected in the bear/bull scenarios.
• Because forecast ROE is high, ROE has been capped at 50% for calculation purposes (the differences between scenarios may therefore appear small).
• Net assets as of the end of the quarter have been used (there is a timing difference from the full-year forecast).

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-06 / This figure does not forecast or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated by AI through an integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.

---End of Report---